Question 1

What does peer-reviewed research say about these claims?

Accepted Answer

Bro translation: The clip contains no claims about serious conditions (cancer, autoimmunity, etc.) that would require mainstream medical consensus to be evaluated. The advice given (lift heavy, eat steak, walk, hit protein goals) is general lifestyle advice that is broadly supported by mainstream evidence and does not contradict medical consensus. Therefore, there is no evidence gap to identify in this specific content.

Question 2

Are Taylor Premer's credentials legitimate?

Accepted Answer

The subject identifies as a Chiropractor (DC) and contrasts their lifestyle-focused approach with a stereotypical 'medical' chiropractor. No evidence of using a narrow credential to claim broad medical authority in this specific clip. Stated credentials: none detected. Likely credentials: Chiropractor (DC), DC.

Question 3

Is Dr Taylor Premer a real medical doctor?

Accepted Answer

Taylor Premer is not identified as an MD/DO physician in reviewed credentials or public registry data. Likely credential: Chiropractor (DC).

Question 4

Is the claim "everyone's care should be personalized" supported by medical literature?

Accepted Answer

High-level frameworks increasingly endorse moving away from one-size-fits-all care toward individualized or stratified approaches. Modern guidelines emphasize tailoring within evidence-based protocols, for example hypertension management uses guideline-directed therapy but adjusts drug class, dosing, and targets based on age, comorbidities, race/ethnicity, and treatment response, which is a form of structured personalization. Clinical nutrition guidelines for inflammatory bowel disease similarly stress individual assessment of nutritional status, disease activity, and complications to select enteral, parenteral, or oral strategies adapted to the patient. Headache guidelines for tension-type headache recommend different pharmacologic and nonpharmacologic options selected according to headache frequency, comorbidities, and patient preference, again reflecting personalized planning inside guideline boundaries. Beyond these specific guidelines, contemporary reviews of personalized and precision medicine in oncology, diabetes, autoimmune disease, and pharmacogenomics consistently argue that tailoring therapy to genetic, molecular, environmental, and lifestyle characteristics improves efficacy and safety and is seen as the future direction of care, supporting the general principle that more individualized care is beneficial for many conditions. Personalized medicine reviews and scoping work in cancer and other chronic diseases describe improved targeting of therapies and reduced adverse effects when care is individualized to patient subgroups and profiles, and generative AI and in silico methods are being developed specifically to enhance patient-centric, individualized decisions. Overall, high-quality reviews and policy statements support the idea that care quality is improved when decisions are made at the level of the individual or well-defined subgroups rather than assuming a single approach fits everyone. Major evidence-based guidelines do not support unconstrained personalization that ignores standardized, trial-tested protocols, and they emphasize starting from population-derived evidence before individual tailoring. Precision-medicine literature explicitly warns against the misconception that "personalized" means entirely unique treatments for each individual; instead, it focuses on classifying patients into subpopulations with shared biology or treatment response, not designing completely bespoke care for every person. This contradicts an absolutist interpretation of the claim that "everyone's care should be personalized" if taken to mean wholly individualized, outside evidence-based structures. Many systematic reviews and guideline-overviews highlight that for numerous routine conditions, standard guideline-based care performs well for most patients and that data to support full personalization for all people and all conditions are limited. Precision medicine reviews repeatedly note challenges such as cost, data requirements, regulatory and ethical issues, and lack of robust predictive markers for many diseases, indicating that universal, fully personalized care is not yet feasible and often not supported by strong evidence outside selected areas like oncology or specific pharmacogenomic use-cases. Scoping reviews of personalized immunotherapy in sepsis show that only a minority of trials incorporate true personalized stratification, and results are often conflicting, underscoring that personalization is still experimental in many acute and complex conditions and not yet a standard for "everyone" in all contexts. The mainstream medical position is that care should be evidence-based and guideline-driven, with structured personalization layered on top rather than fully bespoke care for every individual. Clinical practice guidelines in areas such as hypertension, inflammatory bowel disease, and headache start from high-quality trial data and consensus, then recommend tailoring treatment choices and intensity to the patient's risk profile, comorbidities, preferences, and treatment response, illustrating a balance between standardized frameworks and individualization. Contemporary definitions of precision and personalized medicine emphasize adapting treatment to individual characteristics, but clarify that this typically means assigning patients to biologically or clinically defined subgroups rather than creating unique therapies for each person. In oncology, autoimmune disease, and some chronic conditions, mainstream practice increasingly incorporates genomic and molecular profiling to individualize therapy within established algorithms, while recognizing substantial limits in other fields. Overall, mainstream medicine supports the principle that good care should be individualized where meaningful patient differences exist, but insists this personalization remain anchored in robust, population-based evidence and is not yet practical or proven for every condition or every aspect of care. Literature verdict: partially supported.

Question 5

Is the claim "hit your protein goals" supported by medical literature?

Accepted Answer

High-quality evidence supports the general recommendation that adults should meet at least the Recommended Dietary Allowance (RDA) for protein (about 0.8 g/kg/day) to maintain nitrogen balance and basic health, based on meta-analyses of nitrogen balance studies that underpin current dietary reference intakes.[4][9][15] Systematic reviews and meta-analyses show that increasing protein intake above the RDA, especially in combination with resistance training, produces small but meaningful gains in lean body mass and lower body strength in healthy adults, indicating benefit for body composition and functional capacity.[5][8][14][13] Randomized trials and meta-analyses in older adults indicate that protein intakes at or modestly above the RDA help maintain lean body mass and may reduce hip fracture risk and bone mineral density loss, suggesting that consistently hitting or slightly exceeding protein goals is particularly important in aging populations.[10][19] Systematic reviews of bone health find that higher protein intake (above RDA) is associated with reduced hip fracture risk and generally better bone outcomes, further supporting the value of adequate protein intake across the lifespan.[10][19] Large observational and systematic-review data show no clear overall harm of protein intakes modestly above RDA for major outcomes such as cardiovascular disease and chronic kidney disease in generally healthy adults, and in some analyses higher total, plant, or animal protein is associated with lower incident CKD risk.[6][17][9][12] Some randomized trials in specific populations (e.g., functionally limited older adults receiving testosterone) have found that protein intake above the RDA did not further increase lean body mass or strength compared with RDA-level intake, suggesting that simply exceeding protein goals does not always confer additional benefit beyond adequacy.[11] Umbrella and systematic reviews on protein and chronic disease show that evidence is often graded as “possible” or “probable” for no strong association between total protein intake and major cardiovascular endpoints, and relationships between high protein intake and mortality or cancer are frequently inconclusive, indicating that claims of broad health benefits from very high protein intake are not firmly supported.[9][12] Some evidence suggests potential risks with particular protein sources at high intakes, such as a positive association between high dairy protein intake (>30 g/day) and prostate cancer risk, and possible adverse cardiovascular mortality with long-term low-carbohydrate, high-protein diets, so indiscriminate pursuit of very high protein goals without regard to source and overall diet quality is not clearly supported.[9][21] Very high protein intake, especially with low fiber and high animal protein, can alter gut microbiota function (e.g., increasing TMAO and certain short-chain fatty acids), raising theoretical concerns about long-term cardiometabolic effects, though clinical significance remains uncertain.[16] Mainstream medical and nutrition guidance supports ensuring that adults consistently meet at least the RDA for protein (about 0.8 g/kg/day, varying slightly by country) as a minimum to avoid deficiency and maintain basic physiological functions, with higher intakes within accepted macronutrient distribution ranges often recommended for older adults, athletes, or those seeking to optimize muscle mass and strength.[4][9][15][5][8][14] Current evidence indicates that modestly higher protein intakes than the RDA, particularly when combined with resistance training, can produce small additional benefits for lean body mass, strength, and bone health, while remaining within generally safe limits for healthy individuals.[5][8][10][14][19] At the same time, mainstream positions emphasize that protein goals should be individualized (age, kidney function, physical activity, comorbidities), that overall dietary pattern and protein source (animal vs plant) matter, and that very high protein intakes or high intakes of specific sources like dairy protein may carry some disease-specific risks, so “hitting your protein goals” is framed as achieving adequate but not excessive intake within a balanced diet rather than maximizing protein at all costs.[9][12][17][18][21] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim). Literature verdict: partially supported.

Question 6

Is the claim "eat more steak" supported by medical literature?

Accepted Answer

The specific indexed EAT-Lancet diet meta-analysis indicates that adhering to its recommendations on red meat (which involve limiting rather than increasing intake) is associated with benefits for type 2 diabetes risk, but this is about controlled, modest intake, not eating more steak . Beyond the indexed list, a recent systematic review and meta-analysis of intervention studies found that increasing red meat intake can improve iron status in adults, with longer interventions (≥8–16 weeks) producing small but statistically significant increases in serum ferritin and hemoglobin, which could be helpful in iron-deficiency or suboptimal iron status. RCTs and metabolic feeding trials show that, in the context of otherwise controlled diets, moderate amounts of unprocessed beef do not markedly worsen most lipid parameters, though small LDL increases can occur, suggesting that limited steak intake can be compatible with cardiometabolic health in some individuals. Overall, high-quality evidence supports some specific benefits of red meat (e.g., bioavailable iron and B12) when used to correct deficiency, but not a general recommendation to “eat more steak” for the average person. High-level evidence (umbrella reviews and large meta-analyses) consistently finds that higher total red and processed meat intake is associated with increased risk of all-cause mortality, cardiovascular disease, type 2 diabetes, hypertension, stroke, and nonalcoholic fatty liver disease, with dose–response relationships showing risk rising as daily red meat intake increases. Observational data and comparative risk assessments attribute substantial cardiometabolic deaths to high processed meat consumption, and major public health analyses typically list red and processed meat among dietary factors contributing to cardiometabolic burden. A large 2022 analysis of unprocessed red meat found weak but still positive associations between higher intake and colorectal cancer, breast cancer, ischemic heart disease, and type 2 diabetes, with risk minimized at very low intake, even though uncertainty intervals were wide. Systematic reviews on NAFLD show that both processed and unprocessed red meat are significantly associated with higher disease risk, with clear linear increases in risk for processed meat as intake rises. Although some RCTs and meta-analyses report minimal short-term changes in lipids or weight with higher unprocessed beef in controlled settings, these do not counter the long-term epidemiologic signal that more red meat (including steak) generally worsens chronic disease risk; instead, they highlight that harm is cumulative and context dependent rather than immediate. Overall, the weight and quality of evidence contradicts a blanket recommendation to eat more steak, especially above modest, guideline-level amounts. Mainstream medical and public health guidance does not endorse a general “eat more steak” message; instead, major guidelines recommend limiting red meat (particularly processed forms) to modest amounts, emphasizing plant-based proteins, fish, and poultry for cardiometabolic and cancer risk reduction. Frameworks aligned with the EAT-Lancet Commission, as reflected in its systematic review and meta-analysis, recommend keeping red meat intake relatively low while meeting nutritional needs through diverse, mainly plant-based foods and modest animal-sourced foods . Contemporary evidence syntheses view red and processed meat as more harmful than beneficial at higher intakes, and clinical guidance typically suggests that individuals with increased cardiovascular, metabolic, or liver risk should reduce red meat rather than increase it. While clinicians acknowledge that lean, unprocessed steak in moderation can fit into a healthy diet and may be useful for specific cases like iron deficiency, the prevailing position is that population-level health is better served by limiting red meat, not encouraging people to eat more of it. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim). Literature verdict: mixed.

Taylor Premer alias The Steak & Spine Chiro

Score breakdown

Key findings

Claims & evidence

Manipulation

Borrowed authority & guest funnel

Host self-funnel

Commerce & grift map

Credentials & scope

General Chiropractic Board Standards

Tip the jar

Fight disinformation

Log a new mention

Reply snippets

Recent mentions (this doc)

Nudge the Doc Bro

Pick a contact address

What gets sent

Know someone who can help?

Who should we nudge?

What gets sent

Whambulance

Public challenge log

File a challenge

Citations